Compare Smith & Nephew plc (SNN) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Tempus AI — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Tempus AI trades at $49 (market cap $8.69B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays a 2.57% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| SNN | TEM | |
|---|---|---|
Market Cap | $12.64B | $8.69B |
Sector | Health | Broad Market / Factor |
52-Week High | $38.70 | $103.25 |
52-Week Low | $28.73 | $42.37 |
Enterprise Value | $15.41B | $9.37B |
Dividend Yield | 2.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
